Aptorum Group Limited (NASDAQ: APM) Stock Information | RedChip

Aptorum Group Limited (NASDAQ: APM) Listen to this Section


$3.25
+0.0799 ( +2.52% ) 24.3K

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Market Data


Open


$3.25

Previous close


$3.17

Volume


24.3K

Market cap


$17.29M

Day range


$3.21 - $3.44

52 week range


$1.35 - $17.49

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 Aug 09, 2024
6-k Quarterly Reports 2 May 31, 2024
6-k Quarterly Reports 3 Apr 30, 2024
20-f Annual reports 126 Apr 30, 2024
6-k Quarterly Reports 6 Mar 06, 2024
6-k Quarterly Reports 91 Dec 22, 2023
6-k Quarterly Reports 3 Dec 21, 2023
6-k Quarterly Reports 1 Nov 30, 2023
6-k/a Quarterly Reports 1 Nov 21, 2023
6-k Quarterly Reports 7 Nov 16, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.